Guantao advises Zhengye Biotechnology (ZYBT) on its successful listing on NASDAQ
On January 8, 2025 (January 7 EST), Zhengye Biotechnology Holding Limited ("Zhengye Biotechnology" or the “Company”, stock code: ZYBT) was listed on the NASDAQ Stock Market, marking its status as the first company from Jilin Province and the first in China’s domestic veterinary vaccine industry to go public in the United States.
Through Jilin Zhengye Biological Products Co., Ltd., the Company’s operating entity founded in 2004 in the Jilin Economic and Technological Development Zone, Zhengye Biotechnology focuses on the research, development, manufacturing and sales of veterinary biological products. The operating entity has been approved to establish the Jilin Provincial Engineering Research Center for Animal Vaccines and the Jilin Provincial Animal Vaccine Technology Innovation Center. The operating entity has 14 GMP production lines for advanced technologies such as cell suspension culture and genetic engineering vaccines, with over 40 product approvals and 80 product specifications covering vaccines for livestock (swine, cattle, goats, sheep) and pets. The operating entity’s products are available in 29 provincial regions across China and exported to Vietnam, Pakistan, and Egypt, earning it recognition as a “Jilin Provincial Demonstration Enterprise for Veterinary Biological Products Export”.
In this IPO, Guantao Hangzhou Office acted as PRC legal counsel for Zhengye Biotechnology and offered comprehensive legal services, which included delisting from the NEEQ (National Equities Exchange and Quotations), restructuring and IPO structure design, CSRC (China Securities Regulatory Commission) filings, and full-cycle legal support throughout the listing process.
Guantao team, led by partner Zou Jun and assisted by senior associates Cao Yujia and Dai Ming, delivered end-to-end, professional, and efficient services to Zhengye Biotechnology. Guantao partner Dong Liya, paralegal Huang Yi and secretary Yuan Xunuo also provided support to the team.
Guantao has leveraged its extensive expertise in capital markets, cross-border transactions, and data compliance to deliver professionally rigorous and highly efficient legal services, earning strong client acclaim for its exceptional performance.